High Purity 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic Acid: Your Trusted Pharmaceutical Intermediate Supplier in China

Discover the critical role of 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic Acid (CAS: 763114-26-7) in pharmaceutical synthesis. As a leading manufacturer and supplier in China, we provide high-purity intermediates essential for Olaparib production and advanced organic synthesis.

Get a Quote & Sample

Advantages of Partnering with Us for Your Intermediate Needs

Exceptional Purity & Quality Assurance

Our 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic Acid boasts a purity of 99% min, ensuring reliable and reproducible results in your pharmaceutical synthesis. We adhere to stringent quality control measures to guarantee product excellence.

Direct Manufacturer & Reliable Supply

As a direct manufacturer and supplier based in China, we offer competitive pricing and ensure a consistent, stable supply of this essential Olaparib intermediate, meeting your production demands efficiently.

Expert Support for Your Synthesis Projects

Leverage our deep expertise in chemical intermediates. We provide comprehensive technical data and support to facilitate your laboratory research and optimize your production processes for Olaparib and other advanced pharmaceuticals.

Key Applications in Pharmaceutical Development

Olaparib Synthesis

This intermediate is indispensable for the synthesis of Olaparib, a targeted therapy for certain types of cancer, offering significant value to pharmaceutical manufacturers and researchers.

Advanced Organic Synthesis

Its unique chemical structure makes it a versatile building block for various complex organic synthesis pathways in drug discovery and development.

Biochemical Production Processes

Facilitates efficient biochemical production, supporting the scale-up of pharmaceutical ingredients and complex molecules.

Laboratory Research & Development

A critical reagent for R&D scientists exploring new therapeutic agents and chemical methodologies, supporting innovation in the pharmaceutical sector.